Transmedics
TMDX
60 hedge funds and large institutions have $284M invested in Transmedics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 3 reducing their positions, and 6 closing their positions.
1,067% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 3
167% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 6
20% more funds holding
Funds holding: 50 → 60 (+10)
2.98% more ownership
Funds ownership: 67.71% → 70.69% (+3%)
16% less capital invested
Capital invested by funds: $337M → $284M (-$52.6M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.58M |
| 2 |
BlackRock
New York
|
+$9.37M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$6.71M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.54M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$46.5M |
| 2 |
ZP
Zimmer Partners
New York
|
-$1.1M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.03M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$598K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$585K |
TMDX Hedge Fund Activity: Q4 2019 in Review
60 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2019, worth a combined $284M — down 16% from $337M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new TMDX positions and 6 closed out — a net gain of 10 holders — while 35 added to existing stakes and 3 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $9.58M. The largest seller was Flagship Pioneering, exiting entirely with an estimated $46.5M sold.
- 60 institutional investors held Transmedics (TMDX) as of Q4 2019, up from 50 in Q3 2019.
- Funds reported $284M of Transmedics stock for Q4 2019, down 16% quarter-over-quarter.
- 16 funds opened new Transmedics positions in Q4 2019 and 6 closed out, a net change of +10 holders.
- The largest Transmedics buyer in Q4 2019 was T. Rowe Price Associates, an estimated $9.58M added.
- The largest Transmedics seller in Q4 2019 was Flagship Pioneering, an estimated $46.5M sold.
Based on aggregated 13F filings for Q4 2019.